Hematopoietic stem-cell transplantation (HSCT) has successfully been used t
o cure many pediatric disorders. However, the immunologic alterations assoc
iated with transplantation result in profound immunodeficiencies in the tra
nsplant recipient, resulting in significant infectious morbidity and mortal
ity. The precarious process of immune reconstitution in the transplant reci
pient is neither instantaneous nor complete, but influenced by multiple fac
tors such as graft-versus-host disease (GVHD), conditioning regimen, patien
t age and underlying disease. Studies in pediatric HSCT have revealed uniqu
e attributes of immune recovery in pediatric transplant recipients. Future
studies addressing these findings are needed to complement novel immunother
apies emerging from the field of transplant immunology.